» Articles » PMID: 18805475

The Potential of South African Plants Against Mycobacterium Infections

Overview
Date 2008 Sep 23
PMID 18805475
Citations 33
Authors
Affiliations
Soon will be listed here.
Abstract

Ethnopharmacological Relevance: In South Africa, tuberculosis (TB) caused by Mycobacterium tuberculosis is the most commonly notified disease and the fifth largest cause of mortality, with one in ten cases of TB resistant to treatment in some areas. Many plants are used locally in traditional medicine to treat TB-related symptoms.

Aim Of The Study: The aim was to summarize currently available knowledge on South African plants used to treat TB symptoms, and antimycobacterial efficacy of plant-derived extracts and compounds.

Materials And Methods: The traditional uses of plants for respiratory ailments and TB were collated and tabulated. The antimycobacterial activity tests of extracts and chemical constituents of several of these plants and others using different methods and target organisms were summarized.

Results: Almost 180 plants used for TB-related symptoms in South African traditional medicine were documented. About 30% of these have been tested for antimycobacterial efficacy, mostly against fast-growing, non-pathogenic Mycobacterium species.

Conclusions: Many plant species are used in traditional South African medicine to alleviate symptoms of TB, and several interesting leads have originated for further inquiry following in vitro antimycobacterial activity evaluation. However, much work remains to be done on the systematic assessment of anti-TB efficacy of local plants against pathogenic Mycobacterium species, both in vitro and in vivo.

Citing Articles

Antibacterial Activity and Untargeted Metabolomics Profiling of Poepp.

Thesnor V, Molinie R, Giebelhaus R, de la Mata Espinosa A, Harynuk J, Benimelis D Molecules. 2023; 28(23).

PMID: 38067611 PMC: 10708339. DOI: 10.3390/molecules28237882.


Potential of the Acetone Leaf Extract and Fractions of (Eckl.) Vatke (Rubiaceae) to Combat Co-Infection of Tuberculosis and Helminthiasis.

Aro A, Famuyide I, Oyagbemi A, Kabongo-Kayoka P, McGaw L Front Pharmacol. 2022; 12:744137.

PMID: 35087402 PMC: 8787188. DOI: 10.3389/fphar.2021.744137.


Advances in adjunct therapy against tuberculosis: Deciphering the emerging role of phytochemicals.

Fatima S, Kumari A, Dwivedi V MedComm (2020). 2022; 2(4):494-513.

PMID: 34977867 PMC: 8706769. DOI: 10.1002/mco2.82.


The attenuation of antibiotic resistant non-albicans species, cytotoxicity, anti-inflammatory effects and phytochemical profiles of five species by FTIR and UHPLC-Q/Orbitrap/MS.

More G, Chokwe C, Meddows-Taylor S Heliyon. 2021; 7(11):e08425.

PMID: 34877423 PMC: 8632836. DOI: 10.1016/j.heliyon.2021.e08425.


Metabolomic Profiling of Antioxidant Compounds in Five Species.

More G, Meddows-Taylor S, Prinsloo G Molecules. 2021; 26(20).

PMID: 34684798 PMC: 8539452. DOI: 10.3390/molecules26206214.